The novel myosin activator, danicamtiv alters both systolic and diastolic functions in vitro and in vivo

Back

HFA Premium Access

The novel myosin activator, danicamtiv alters both systolic and diastolic functions in vitro and in vivo

Session: ePosters in basic science 2

Topic: Heart Failure

Speaker: Doctor A. Raduly (Debrecen, HU)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Arnold Peter Raduly

University of Debrecen, Debrecen (Hungary)

0 follower

7 more presentations in this session

DETECT-Heart: biomarkers for screening of patients referred to the cardiovascular outpatient clinic

Speaker: Mr C. Geraeds (Maastricht, NL)

The predictive value of matrix metalloproteinase-9 as an inflammation marker in anticipating adverse events one year after experiencing a st-elevation myocardial infarction

Speaker: Associate Professor I. Vyshnevska (Kharkiv, UA)

HFWM: evaluating the importance of myeloperoxidase in the early anticipation of subsequent chronic heart failure occurrences in individuals after st-segment elevation acute myocardial infarction

Speaker: Associate Professor I. Vyshnevska (Kharkiv, UA)

MicroRNA-based network analysis identified the NOVA1 gene as a potential new target in end-stage heart failure

Speaker: Miss T. Balint (Budapest, HU)

Novel insights in cardiac fibrosis in HFpEF: potential role of UBALD2-enriched endothelial extracellular vesicles

Speaker: Miss B. Losada Fuentenebro (Pamplona, ES)

Access the full session

ePosters in basic science 2

Speakers: Doctor A. Raduly, Mr C. Geraeds, Associate Professor I. Vyshnevska, Associate Professor I. Vyshnevska, Miss T. Balint...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources